Application 201831

Type
ANDA
Sponsor
GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DESMOPRESSIN ACETATEDESMOPRESSIN ACETATETABLET;ORAL0.1MGNoNo
002DESMOPRESSIN ACETATEDESMOPRESSIN ACETATETABLET;ORAL0.2MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-883Desmopressin AcetateDesmopressin AcetateNorthstar Rx LLCANDACurrent
16714-884Desmopressin AcetateDesmopressin AcetateNorthstar Rx LLCANDACurrent
68001-325Desmopressin AcetateDesmopressin AcetateBluePoint LaboratoriesANDACurrent
68001-325Desmopressin AcetateDesmopressin AcetateBluePoint LaboratoriesANDACurrent
68001-326Desmopressin AcetateDesmopressin AcetateBluePoint LaboratoriesANDACurrent
68001-326Desmopressin AcetateDesmopressin AcetateBluePoint LaboratoriesANDACurrent
68462-275Desmopressin AcetateDesmopressin AcetateGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-275Desmopressin AcetateDesmopressin AcetateGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-276Desmopressin AcetateDesmopressin AcetateGlenmark Pharmaceuticals Inc.,USAANDACurrent
68462-276Desmopressin AcetateDesmopressin AcetateGlenmark Pharmaceuticals Inc.,USAANDACurrent
70518-3125Desmopressin AcetateDesmopressin AcetateREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
32141ORIG2015-05-29